News
4h
Zacks Investment Research on MSNAstraZeneca Stock Declines 6% in 3 Months: Time to Buy the Dip?AstraZeneca AZN stock has declined 6.4% in the past three months. Although AstraZeneca faces its share of challenges, a ...
The U.S. Department of Health and Human Services said on Tuesday it would set drug prices pegged to the lowest level paid by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results